LDS/Medical Tests/C-Reactive Protein (CRP), Qualitative or Quantitative

C-Reactive Protein (CRP), Qualitative or Quantitative

C-reactive protein (CRP) is a liver-synthesized protein in response to inflammation. Its secretion is stimulated by inflammatory cytokines. After its immediate response to inflammatory cytokines, CRP levels are detectable within 4 to 6 hours and the peak value is reached within 24 to 48 hours. Often levels increase over 100 times the normal value. Unlike other acute phase proteins, CRP is not affected by hormones. CRP is involved in the activation of the classical complement pathway by binding to phosphocholine on the surface of dying cells and some bacteria and other microbes and serve as an opsonin (labeling foreign bodies for destruction and elimination by the immune system).

Elevated levels of CRP are seen in inflammation, myocardial infarction, infection, trauma, tissue necrosis, surgery, malignancies, and autoimmune disorders. In addition to its use as an inflammatory marker, CRP has been shown to be an independent risk factor for atherosclerotic disease. Elevated CRP levels are associated with increased cardiovascular morbidity and mortality in patients with coronary artery disease. In addition to arteriosclerosis, increased CRP levels are seen in patients with rheumatoid arthritis and other autoimmune diseases.

Patients with increased CRP by high-sensitivity assay (a new generation of sensitive CRP assay) are more likely to develop stroke, myocardial infarction, and severe peripheral vascular disease. Non-cardiovascular causes of CRP elevation should be considered if CRP values are >10 mg/dL with repeat measurements.

  • As an aid in diagnosis of acute myocardial infarction and acute coronary syndromes
  • As an aid in diagnosis of sepsis and other acute infections
  • As an aid in diagnosis of diseases with severe inflammation
  • As an aid in diagnosis of autoimmune disease
  • In postoperative monitoring
  • As an aid in diagnosis of pelvic inflammatory disease (PID)
  • In diagnosis of acute appendicitis

Increased in:

  • Arteriosclerotic disorders
  • Myocardial infarction
  • Ischemic stroke
  • Peripheral arterial disease
  • Sepsis and other inflammatory states
  • Rheumatoid arthritis and other autoimmune disease
  • Trauma (surgery, necrosis)

Less than 1.0 mg/L (Low Risk)
1.0-3.0 mg/L (Average Risk)
3.1-9.9 mg/L (High Risk)
Greater than 9.9 mg/L (Very High Risk)

 

 

Immunoassay, Enzyme-linked immunosorbent assay (ELISA), Immunonephelometry, Immunoturbidimetry

Serum (SST), Plasma Heparin (Green), EDTA (Lavender).

Stability

  • Ambient: 5-7 days
  • Refrigerated: 7- 14 days
  • Frozen: 12 months
  • Separate serum immediately and keep refrigerated or frozen.
Erythrocyte Sedimentation rate, comprehensive metabolic panel, lipid panel, albumin, alpha-1-antitrypsin, bacterial culture, haptoglobin, hypercoagulation panel, fibrinogen, Group A strep by PCR, Complement components C3, C4, CBC with differential, ANA, Troponin, CK-MB, total CK, Inflammatory bowel disease serology panel, Rheumatoid factor.
Same day.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Biol Chem. 2004 Nov 19;279(47):48487-90. [PMID: 15337754]
  • Adv Intern Med. 1982;27:345-72. [PMID: 7041546]
  • Diabetes Technol Ther. 2006 Feb;8(1):28-36. [PMID: 16472048]
  • Curr Opin Rheumatol. 2004;16:18. [PMID: 1473384]
  • Autoimmun Rev. 2006;5:331. [PMID: 16782558]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757